• 1
    Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 126173.
  • 2
    Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut 1998; 43: 70510.
  • 3
    Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life in patients with primary biliary cirrhosis. Am J Gastroenterol 2000; 95: 7607.
    Direct Link:
  • 4
    Goldblatt J, Taylor PJS, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002; 122: 123541.
  • 5
    Poupon RE, Chretien Y, Chazouilleres O, Poupon R, Chwalow J. Quality of life in patients with primary biliary cirrhosis. Hepatology 2004; 40: 48994.
  • 6
    Forton D, Patel N, Prince M, et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetization transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004; 53: 58792.
  • 7
    Swain MG, Le T. Chronic cholestasis in rats induces anhedonia and loss of social interest. Hepatology 1998; 28: 610.
  • 8
    Kerfoot SM, D'Mello C, Nguyen H, et al. TNF-alpha secreting monocytes are recruited into the brain of cholestatic mice. Hepatology 2006; 43: 15462.
  • 9
    Jones DEJ, Newton JL. Primary biliary cirrhosis. Horiz Med 2006; 17: 30715.
  • 10
    Newton JL, Gibson JG, Tomlinson M, Wilton K, Jones DEJ. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006; 44: 918.
  • 11
    Boivin DB, Montplaisir J, Petei D, Lambert C, Lubin S. Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol 1993; 16: 4653.
  • 12
    Besset A, Chetrit M, Carlander B, Billiard M. Use of modafinil in the treatment of narcolepsy: a long-term follow-up study. Neurophysiol Clin 1996; 26: 6066.
  • 13
    Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164: 167581.
  • 14
    Czeisler CA, Walsh JK, Roth T, et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med 2005; 353: 51921.
  • 15
    Kaplan MM, Bonis PAL. Modafinil for the treatment of fatigue in primary biliary cirrhosis. Ann Int Med 2005; 143: 546.
  • 16
    Metcalf JV, Howel D, James OFW, Bhopal RS. Primary biliary cirrhosis: epidemiology helping the clinician. Br Med J 1996; 312: 11812
  • 17
    Johns M. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994; 17: 70310.
  • 18
    Jacoby A, Rannard A, Buck D, et al. Development, validation and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut 2005; 54: 16229.
  • 19
    Newton JL, Bhala N, Burt J, Jones DEJ. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol 2006; 44: 77682.
  • 20
    Becker PM, Schwartz JR, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology 2004; 171: 1339.
  • 21
    Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ. Modafinil treatment for fatigue in HIV+ patients: a pilot study. J Clin Psych 2004; 65: 168895.
  • 22
    Thase ME, Fava M, DeBattista C, Arora S, Hughes RJ. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr 2006; 11: 93102.
  • 23
    Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfield AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg, Psychiatry 2002; 72: 17983.
  • 24
    Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. Modafinil in treatment of fatigue in multiple sclerosis. J Neurol 2002; 49: 9837.
  • 25
    Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons form the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 2004; 27: 1925.
  • 26
    Hou RH, Freeman C, Langley RW, Szabadi E, Bradshaw CM. Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology 2005; 181: 53749.
  • 27
    Taneja I, Diedrich A, Black BK, Byrne DW, Paranjape SY, Robertson D. Modafinil elicits sympathomedullary activation. Hypertension 2005; 45: 6128.
  • 28
    Newton JL, Allen J, Kerr S, Jones DEJ. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int 2006; 26: 197202.
  • 29
    Newton JL, Davidson A, Kerr S, et al. Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol 2007; in press.
  • 30
    Hart CL, Haney M, Vosburg SK, Comer CD, Gunderson E, Foltin RW. Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology 2006; 31: 152636.
  • 31
    Jones EA. Personal view: a potential novel treatment for fatigue complicating chronic liver disease-how should its efficacy be evaluated? Aliment Pharmacol Therap 2006; 23: 11136.
  • 32
    Jones DE, Bhala N, Burt J, Goldblatt J, Prince MI, Newton JL. Four year follow-up of fatigue in a geographically-defined primary biliary cirrhosis patient cohort. Gut 2006; 55: 53641.
  • 33
    Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 2005; 64: 113943.
  • 34
    Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72: 17983.